The Indirect Costs of Morbidity in Type II Diabetic Patients
In an attempt to obtain an appropriate estimate of the excess costs of production losses arising from morbidity in patients with diabetes, we compared the number of sick days and permanently disabled individuals in a diabetic population and the corresponding general population. These comparisons show that the rate of premature retirement for both insulin-dependent diabetes mellitus (IDDM, type I diabetes) or non-insulin-dependent diabetes mellitus (NIDDM, type II diabetes) patients was twice that of the average population. Insulin-treated subjects also had twice as many sickness benefit days. The excess costs of production losses as a result of morbidity in people aged 20 to 64 years with type II diabetes were about $US7000 per individual and year. Most of these excess costs were attributed to permanent disability in the 40- to 64-year age groups.
KeywordsProduction Loss Excess Cost Permanent Disability Sickness Benefit Disable Individual
Unable to display preview. Download preview PDF.
- 3.Lindgren B. Cost of illness in Sweden 1964–1975. Lund Economic Studies: Lund, Sweden: 1981Google Scholar
- 4.Statistics Sweden: Income distribution survey in 1990. Stockholm, 1992 (Be 21 SN 9201)Google Scholar
- 5.Jonsson B, Persson U. Diabetes: A study in health economics. Lund, Sweden, The Swedish Institute for Health Economics, 1981 (!HE report 1981:7)Google Scholar